🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the ability of subjects who are alr...
Status
Completed
Location
Ra0098 116
Start Date
2017-11-03
Trial ID
NCT03357471
Treatments Being Tested
The study is a Phase 3, multicenter, randomized, double-blind, placebo-cont...
Status
Completed
Location
961
Start Date
2010-03
Trial ID
NCT01087762
Treatments Being Tested
A Multicenter, Open-label Study to Assess the Pharmacokinetics, Safety and ...
Status
Completed
Location
Ra0043 71
Start Date
2012-03-08
Trial ID
NCT01550003
Treatments Being Tested
This study will continue to evaluate the safety \& efficacy of Certolizumab...
Status
Completed
Location
037
Start Date
2014-11
Trial ID
NCT02319642
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of two ...
Status
Completed
Location
Ps0003 317
Start Date
2015-02-11
Trial ID
NCT02346240
Treatments Being Tested
Patients with active Axial Spondyloarthritis without x-ray evidence of Anky...
Status
Completed
Location
As0006 125
Start Date
2015-09
Trial ID
NCT02552212
Treatments Being Tested
This study is intended to evaluate the efficacy and safety of Certolizumab ...
Status
Completed
Location
209
Start Date
2012-01
Trial ID
NCT01521923
Treatments Being Tested
Phase 3, multicenter, randomized, double-blind, parallel-group, placebo-con...
Status
Completed
Location
961
Start Date
2010-03
Trial ID
NCT01087788
Treatments Being Tested
The purpose of the study is to assess efficacy, safety and tolerability of ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-06
Trial ID
NCT04643483
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of two ...
Status
Completed
Location
Ps0002 203
Start Date
2014-12-15
Trial ID
NCT02326272
Treatments Being Tested